Year: 2020

news_6

CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet” and Contributes to Accelerating Provision for COVID-19 Patients

TOKYO--(BUSINESS WIRE)--#Avigan--CMIC HOLDINGS Co., Ltd. (Head Office: Tokyo, Minato-ku, Representative Director & CEO Kazuo Nakamura, hereafter “CMIC”) announced today that...

news_6

EpimAb Biotherapeutics and QIMR Berghofer Medical Research Institute Announce Research Collaboration and License Agreement on Novel Bispecific Target Combinations

EpimAb receives exclusive access to newly discovered target combinations in order to expand its proprietary pipeline SHANGHAI & BRISBANE, Australia--(BUSINESS...